223 related articles for article (PubMed ID: 29116170)
1. Injection of high dose botulinum-toxin A leads to impaired skeletal muscle function and damage of the fibrilar and non-fibrilar structures.
Pingel J; Nielsen MS; Lauridsen T; Rix K; Bech M; Alkjaer T; Andersen IT; Nielsen JB; Feidenhansl R
Sci Rep; 2017 Nov; 7(1):14746. PubMed ID: 29116170
[TBL] [Abstract][Full Text] [Related]
2. How muscles recover from paresis and atrophy after intramuscular injection of botulinum toxin A: Study in juvenile rats.
Shen J; Ma J; Lee C; Smith BP; Smith TL; Tan KH; Koman LA
J Orthop Res; 2006 May; 24(5):1128-35. PubMed ID: 16602109
[TBL] [Abstract][Full Text] [Related]
3. The rat Digit Abduction Score (DAS) assay: a physiological model for assessing botulinum neurotoxin-induced skeletal muscle paralysis.
Broide RS; Rubino J; Nicholson GS; Ardila MC; Brown MS; Aoki KR; Francis J
Toxicon; 2013 Sep; 71():18-24. PubMed ID: 23707612
[TBL] [Abstract][Full Text] [Related]
4. Ouabain exacerbates botulinum neurotoxin-induced muscle paralysis via progression of muscle atrophy in mice.
Fujikawa R; Muroi Y; Unno T; Ishii T
J Toxicol Sci; 2010 Dec; 35(6):795-805. PubMed ID: 21139329
[TBL] [Abstract][Full Text] [Related]
5. Dramatic changes in muscle contractile and structural properties after 2 botulinum toxin injections.
Minamoto VB; Suzuki KP; Bremner SN; Lieber RL; Ward SR
Muscle Nerve; 2015 Oct; 52(4):649-57. PubMed ID: 25598004
[TBL] [Abstract][Full Text] [Related]
6. Muscle volume alterations in spastic muscles immediately following botulinum toxin type-A treatment in children with cerebral palsy.
Williams SA; Reid S; Elliott C; Shipman P; Valentine J
Dev Med Child Neurol; 2013 Sep; 55(9):813-20. PubMed ID: 23789782
[TBL] [Abstract][Full Text] [Related]
7. Botulinum neurotoxin type A-cleaved SNAP25 is confined to primary motor neurons and localized on the plasma membrane following intramuscular toxin injection.
Cai BB; Francis J; Brin MF; Broide RS
Neuroscience; 2017 Jun; 352():155-169. PubMed ID: 28389376
[TBL] [Abstract][Full Text] [Related]
8. Bioprotection of tendon repair: adjunctive use of botulinum toxin A in Achilles tendon repair in the rat.
Ma J; Shen J; Smith BP; Ritting A; Smith TL; Koman LA
J Bone Joint Surg Am; 2007 Oct; 89(10):2241-9. PubMed ID: 17908902
[TBL] [Abstract][Full Text] [Related]
9. Skeletal muscle atrophy induced by intramuscular repeated dose of botulinum toxin type A in rats.
Choi WH; Song CW; Kim YB; Ha CS; Yang GH; Woo HD; Jung HH; Koh WS
Drug Chem Toxicol; 2007; 30(3):217-27. PubMed ID: 17613007
[TBL] [Abstract][Full Text] [Related]
10. Systems analysis of transcriptional data provides insights into muscle's biological response to botulinum toxin.
Mukund K; Mathewson M; Minamoto V; Ward SR; Subramaniam S; Lieber RL
Muscle Nerve; 2014 Nov; 50(5):744-58. PubMed ID: 24536034
[TBL] [Abstract][Full Text] [Related]
11. Botulinum Toxin Type A Injection for Spastic Equinovarus Foot in Children with Spastic Cerebral Palsy: Effects on Gait and Foot Pressure Distribution.
Choi JY; Jung S; Rha DW; Park ES
Yonsei Med J; 2016 Mar; 57(2):496-504. PubMed ID: 26847306
[TBL] [Abstract][Full Text] [Related]
12. Intramuscular injection of 125I-botulinum neurotoxin-complex versus 125I-botulinum-free neurotoxin: time course of tissue distribution.
Tang-Liu DD; Aoki KR; Dolly JO; de Paiva A; Houchen TL; Chasseaud LF; Webber C
Toxicon; 2003 Oct; 42(5):461-9. PubMed ID: 14529727
[TBL] [Abstract][Full Text] [Related]
13. A single injection of botulinum toxin decreases the margin of safety of neurotransmission at local and distant sites.
Frick CG; Fink H; Blobner M; Martyn J
Anesth Analg; 2012 Jan; 114(1):102-9. PubMed ID: 22003222
[TBL] [Abstract][Full Text] [Related]
14. Time course of recovery of juvenile skeletal muscle after botulinum toxin A injection: an animal model study.
Ma J; Elsaidi GA; Smith TL; Walker FO; Tan KH; Martin E; Koman LA; Smith BP
Am J Phys Med Rehabil; 2004 Oct; 83(10):774-80; quiz 781-3. PubMed ID: 15385786
[TBL] [Abstract][Full Text] [Related]
15. Capsaicin protects mouse neuromuscular junctions from the neuroparalytic effects of botulinum neurotoxin a.
Thyagarajan B; Krivitskaya N; Potian JG; Hognason K; Garcia CC; McArdle JJ
J Pharmacol Exp Ther; 2009 Nov; 331(2):361-71. PubMed ID: 19654265
[TBL] [Abstract][Full Text] [Related]
16. Comparison between neurectomy and botulinum toxin A injection for denervated skeletal muscle.
Tsai FC; Hsieh MS; Chou CM
J Neurotrauma; 2010 Aug; 27(8):1509-16. PubMed ID: 20528164
[TBL] [Abstract][Full Text] [Related]
17. How effective is physical therapy for gait muscle activity in hemiparetic patients who receive botulinum toxin injections?
Fujita K; Miaki H; Hori H; Kobayashi Y; Nakagawa T
Eur J Phys Rehabil Med; 2019 Feb; 55(1):8-18. PubMed ID: 29898587
[TBL] [Abstract][Full Text] [Related]
18. Muscle volume alterations after first botulinum neurotoxin A treatment in children with cerebral palsy: a 6-month prospective cohort study.
Alexander C; Elliott C; Valentine J; Stannage K; Bear N; Donnelly CJ; Shipman P; Reid S
Dev Med Child Neurol; 2018 Nov; 60(11):1165-1171. PubMed ID: 30151852
[TBL] [Abstract][Full Text] [Related]
19. Quantitative evaluation for spasticity of calf muscle after botulinum toxin injection in patients with cerebral palsy: a pilot study.
Lin YC; Lin IL; Chou TF; Lee HM
J Neuroeng Rehabil; 2016 Mar; 13():25. PubMed ID: 26969526
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of the proteasome partially attenuates atrophy in botulinum neurotoxin treated skeletal muscle.
Houston FE; Hain BA; Dodd SL
Toxicon; 2018 Mar; 144():48-54. PubMed ID: 29407164
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
